ANCA-Associated Vasculitis: Contemporary Perspectives for the Rheumatology Provider – Featuring Curbside Consults

1.25 CME
1.25 AANP
75 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

ANCA-Associated Vasculitis: Contemporary Perspectives for the Rheumatology Provider – Featuring Curbside Consults

Overview


Provider Statement

This continuing education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by educational funding provided by Amgen.

Activity Description

Antineutrophil cytoplasmic antibody–associated vasculitides (AAV) are rare, multisystem, autoimmune diseases causing inflammation and damage to small blood vessels and their surrounding tissues. This group of vasculitides is associated with a high healthcare burden, impact on patient quality of life, increased risk of hospitalization, and mortality. Commonly affected organs include the kidneys, lungs, skin, heart, ear, nose, and throat, as well as the nervous and gastrointestinal systems. Recent advances in therapy offer promising new options to improve patient outcomes while avoiding corticosteroid toxicity. In this program, faculty will review AAV pathophysiology, approaches for early detection and intervention, as well as evidence to support steroid-sparing treatment regimens. This educational activity features Curbside Consults, a dynamic and interactive case-based segment that will highlight strategies to improve the care and lives of patients with AAV.

Target Audience

The intended audience for this activity is rheumatologists, nurse practitioners, physician associates, and other healthcare professionals involved in the management of patients with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Evaluate the significance of the complement alternative pathway in the pathogenesis and treatment of ANCA-associated AAV.
  • List evidence-based tools to facilitate the early detection of AAV.
  • Outline the importance of glucocorticoid toxicity in AAV management.
  • Summarize the clinical evidence for standard-of-care treatments and steroid-sparing therapies in AAV management.
  • Examine interprofessional strategies to improve the care and outcomes of patients with AAV.

Activity Chair

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH

Faculty

Adam J. Brown, MD
Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Anisha B. Dua, MD, MPH
Associate Professor, Fellowship Program Director
Director of the Vasculitis Center
Northwestern University Feinberg School of Medicine
Chicago, IL

David Jayne, MD, FMedSci
Professor of Clinical Autoimmunity
University of Cambridge
Director, Vasculitis and Lupus Service
Addenbrooke’s Hospital
Cambridge, United Kingdom

Kenneth J. Warrington, MD
Chair, Division of Rheumatology
Director, Vasculitis Subspecialty Group
John F. Finn Minnesota Arthritis Foundation Professor of Medicine
Mayo Clinic College of Medicine and Science
Rochester, MN

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C

Accreditation

ACCME Jointly accredited In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

aapa Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 12/30/2024. PAs should only claim credit commensurate with the extent of their participation.

This activity is approved for 1.25 contact hour(s) of continuing education (which includes 0.5 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23126463. This activity was planned in accordance with AANP Accreditation Standards and Policies.

This enduring material is approved for 1 year from the date of original release, December 31, 2023, to December 30, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate, AAPA Category 1 CME Certificate, or AANP Contact Hour Certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Adam J. Brown, MD
Consultant: Amgen

Leonard H. Calabrese, DO
Consultant: AbbVie, Amgen, AstraZeneca, GSK, Regeneron
Speaker Contracted by Ineligible Company: Amgen, AstraZeneca, ChemoCentryx, Regeneron

Anisha B. Dua, MD, MPH
Advisor: AbbVie, ChemoCentryx/Amgen, Novartis
Consultant: AbbVie, ChemoCentryx/Amgen, GSK, Novartis

David Jayne, MD, FMedSci
Advisor: GSK
Consultant: Amgen, AstraZeneca, CSL-Vifor, GSK, Novartis
Speaker Contracted by Ineligible Company: CSL-Vifor, GSK
Independent Research Contractor: CSL-Vifor, GSK

Kenneth J. Warrington, MD
Advisor: Amgen, Sanofi
Independent Research Contractor (paid to institution): Bristol Myers Squibb, Kiniksa

Planners/Reviewers report the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Procedures for Reporting Copyright Infringement

If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by getting in touch with our designated copyright agent (as outlined below). To do so, kindly provide the following details:

  • Specify the copyrighted work you believe has been infringed upon.
  • Describe the work and, if possible, include the location (e.g., URL) of an authorized version of the work.
  • Share your name, address, telephone number, and, if available, your email address.
  • Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
  • Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you either are the copyright owner or have the authority to act on behalf of the copyright owner.
  • Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.

Our agent for copyright issues relating to this web activity is as follows:

Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614

CE Questions?

Contact us at cme@vindicoCME.com